Bromocriptine Mesylate Capsule
Product Images NDC 68382-110

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bromocriptine Mesylate (NDC 68382-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E40bbda0 9db8 440a Ae30 05bf395f7251 01

E40bbda0 9db8 440a Ae30 05bf395f7251 01
Chemical structure of Bromocriptine mesylate, showing the molecular arrangement including a brominated indole ring and mesylate group (CH3SO3H) attached.*
FDA Label Image

E40bbda0 9db8 440a Ae30 05bf395f7251 02

E40bbda0 9db8 440a Ae30 05bf395f7251 02
Label for Bromocriptine Mesylate Capsules USP, 5 mg strength, in a package of 100 capsules. The label shows the NDC number 68382-110-01 and indicates the product is manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals USA Inc. The label includes storage instructions, dosage note, and a barcode, with the Zydus Pharmaceuticals logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.